Fundraising FoxHillhurst Biopharmaceuticals
Montrose, US · Delaware corporation
Find your way into Hillhurst Biopharmaceuticals
Sign up to see every warm intro you have to Hillhurst Biopharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Hillhurst Biopharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
JF
Jeff FriedmanNamed on SEC filing
AG
Andrew GompertsNamed on SEC filing
EG
Edward GompertsNamed on SEC filing
Funding
SEC filings, press & company announcements$1.8M disclosed across 1 of 3 rounds · 2020–2023
- Undisclosed amountPhase 1 Small Business Technology Transfer (STTR) grantSep 2021Source ↗
▶$1.8MraisedSep 2023 · 10 investors · BiotechnologyRule 506(b)
▶$1.8MraisedSep 2023 · 10 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeff FriedmanDirector
- Andrew GompertsExecutive Officer, Director
- Edward GompertsExecutive Officer, Director
- Offering amount
- $1.8M
- Amount sold
- $1.8M
- First sale
- Sep 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Hillhurst Biopharmaceuticals raised?
- Hillhurst Biopharmaceuticals has disclosed $1.8M raised across 1 of its 3 known rounds.
- Where is Hillhurst Biopharmaceuticals headquartered?
- Hillhurst Biopharmaceuticals is headquartered in Montrose, US.